Increased activation of the phosphatidyl-inositol-3 kinase/AKT and NFkB pathways have both been identified as critical pathways in cancer initiation and progression in a variety of human malignancies, including prostate cancer. The gene discussed is NFKB1; the disease is prostate cancer.